Alumis Inc
Headquarters country
Germany
Registry sponsor category
Industry
- Other names
- Alumis Inc
- Company name
- Alumis Inc
- Organisation type
- Industry
- Registered legal name
- Alumis GmbH & Co. KG
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0001847367
- Legal Entity Identifier (LEI)
- 391200MJD7XR8D8HXC35
Related records
Trials (13)
- A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001
- A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis
- An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage
- An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function
- An Investigational Study to Evaluate the Cardiac Safety Assessment (TQTc Study) of ESK-001
- An Investigational Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of A-005
- Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
- Multiple Dose Study to Determine Safety and Tolerability of ESK-001 in Healthy Participants
- Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis
- Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus
- POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU
- Relative Bioavailability of ESK-001 Tablet Versus Liquid in Healthy Participants